Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 2 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Recs

0
Player Avatar vxfrbeva (< 20) Submitted: 2/3/2012 3:20:29 PM : Outperform Start Price: $4.20 CYTX Score: -46.41

Cytori Therapeutics is inmerse in a big moment right now. Their bussines is going to get huge as there is a big market for the stem cells applied to heart recovery after heart atacks and also for the breasts surgery.

Featured Broker Partners


Advertisement